[HTML][HTML] Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort

VT Tran, R Porcher, I Pane, P Ravaud - Nature communications, 2022 - nature.com
… Among the 1859 patients included in the ComPaRe long COVID cohort on October 15, 2021,
we analysed the data from the 968 patients reporting: (1) a laboratory-confirmed COVID-19 …

[HTML][HTML] Course of long COVID symptoms over time in the ComPaRe long COVID prospective e-cohort

V Tran, R Porcher, I Pane, P Ravaud - 2021 - europepmc.org
… infection enrolled in the ComPaRe long COVID cohort, a disease prevalent prospective e-cohort
of such patients in France. Day-by-day prevalence of post COVID-19 symptoms was …

[HTML][HTML] COVID-19–related perceptions, context and attitudes of adults with chronic conditions: Results from a cross-sectional survey nested in the ComPaRe e-cohort

VT Tran, P Ravaud - PloS one, 2020 - journals.plos.org
… chronic conditions during the COVID-19 pandemic to clarify their potential risk of infection. …
In a large case series of 4000 patients hospitalized in ICUs in Italy, the highest risk of death …

… to COVID 19-lockdown restrictions in patients with asthma versus other chronic diseases: results from a cross-sectional survey nested in the ComPaRe e-cohort, in …

C Taille, N Roche, F Tesson, C Tardivon… - Journal of …, 2022 - Taylor & Francis
… ) prevail to explain lower susceptibility to COVID-19. Potential changes in physical activities
or … This large survey emphasizes that self-reported adherence and confidence during the first …

[HTML][HTML] Efficacy of first dose of covid-19 vaccine versus no vaccination on symptoms of patients with long covid: target trial emulation based on ComPaRe e-cohort

VT Tran, E Perrodeau, J Saldanha, I Pane… - BMJ …, 2023 - ncbi.nlm.nih.gov
… Therefore, we used data from a large ongoing prospective cohort of patients with long
covid to emulate a target trial evaluating the effect of vaccinationon the symptoms and on the …

[HTML][HTML] Risk factors for post-COVID-19 condition (Long Covid) in children: a prospective cohort study

R Morello, F Mariani, L Mastrantoni, C De Rose… - …, 2023 - thelancet.com
… approach comparing healthcare … this prospective follow-up study, we aimed to investigate
the long-term duration of persisting symptoms and risk factors for developing of PCC in a large

[HTML][HTML] Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort study

Y Xie, T Choi, Z Al-Aly - The Lancet Infectious Diseases, 2024 - thelancet.com
… groups, we randomly assigned potential follow-up times to … The cumulative difference
between COVID-19 and seasonal … the risk and risk difference between COVID-19 and seasonal …

[HTML][HTML] The effects of COVID-19 on cognitive performance in a community-based cohort: a COVID symptom study biobank prospective cohort study

NJ Cheetham, R Penfold, V Giunchiglia, V Bowyer… - …, 2023 - thelancet.com
… years after recorded COVID-19 diagnosis in comparison to other … , including in cohorts
with long COVID, to our knowledge no … assessment tool, with prospective self-report symptom …

[HTML][HTML] Long-term symptom severity and clinical biomarkers in post-COVID-19/chronic fatigue syndrome: results from a prospective observational cohort

F Legler, L Meyer-Arndt, L Mödl, C Kedor… - …, 2023 - thelancet.com
… The current manuscript analyses follow-up data from a prospective observational cohort
study of patients with severe fatigue and exertion intolerance post COVID-19 diagnosis. …

[HTML][HTML] Characterization of long COVID temporal sub-phenotypes by distributed representation learning from electronic health record data: a cohort study

…, L Lenert, D Leprovost, M Liu, NHW Loh, Q Long… - …, 2023 - thelancet.com
… We estimated that on average 15.7% of the hospitalized COVID-19 patients were likely to
suffer from at least one PASC symptom and almost 5.98%, on average, had multiple symptoms…